NCT05456503View on ClinicalTrials.gov

PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using PI-2620

PHASE3RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions
Frontotemporal Lobar DegenerationAlzheimer DiseaseCognitively Normal
Interventions
DRUG

FPI-2620

Radiotracer

Trial Locations (1)

19104

RECRUITING

Perelman Center for Advance Medicine, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Pennsylvania

OTHER